Proteasome inhibitors as potential novel anticancer agents.
about
Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells.Advances in the understanding of mechanisms and therapeutic use of bortezomibOrganic cadmium complexes as proteasome inhibitors and apoptosis inducers in human breast cancer cellsChemopreventive evaluation of a Schiff base derived copper (II) complex against azoxymethane-induced colorectal cancer in ratsRenal Toxicities of Novel Agents Used for Treatment of Multiple Myeloma.Tumor cellular proteasome inhibition and growth suppression by 8-hydroxyquinoline and clioquinol requires their capabilities to bind copper and transport copper into cells.Comparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.Inhibitory effects of local anesthetics on the proteasome and their biological actions.BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia.Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future.Cellular and computational studies of proteasome inhibition and apoptosis induction in human cancer cells by amino acid Schiff base-copper complexes.Murraya koenigii leaf extract inhibits proteasome activity and induces cell death in breast cancer cells.Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.In vitro and in vivo antitumor activities and DNA binding mode of five coordinated cyclometalated organoplatinum(II) complexes containing biphosphine ligands.Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression.Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'.Computational modeling of the potential interactions of the proteasome beta5 subunit and catechol-O-methyltransferase-resistant EGCG analogs.Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.Black tea polyphenols inhibit tumor proteasome activityProteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.Methylferulate from Tamarix aucheriana inhibits growth and enhances chemosensitivity of human colorectal cancer cells: possible mechanism of action.Nano-liquid Chromatography-orbitrap MS-based Quantitative Proteomics Reveals Differences Between the Mechanisms of Action of Carnosic Acid and Carnosol in Colon Cancer Cells.Heat stress induces epithelial plasticity and cell migration independent of heat shock factor 1.Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenograftsPolyphenols from green tea and pomegranate for prevention of prostate cancer.New applications of old metal-binding drugs in the treatment of human cancer.Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.1,10-Phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.A novel dithiocarbamate analogue with potentially decreased ALDH inhibition has copper-dependent proteasome-inhibitory and apoptosis-inducing activity in human breast cancer cellsCurcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo.Relationship between the methylation status of dietary flavonoids and their growth-inhibitory and apoptosis-inducing activities in human cancer cellsNovel metals and metal complexes as platforms for cancer therapyThe proteasome is a molecular target of environmental toxic organotins.Pyrrolidine dithiocarbamate-zinc(II) and -copper(II) complexes induce apoptosis in tumor cells by inhibiting the proteasomal activity.Disulfiram promotes the conversion of carcinogenic cadmium to a proteasome inhibitor with pro-apoptotic activity in human cancer cells.Molecular mechanisms of green tea polyphenolsThe tumor proteasome as a novel target for gold(III) complexes: implications for breast cancer therapyInduction of tumor cell apoptosis by taurine Schiff base copper complex is associated with the inhibition of proteasomal activityNovel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.Novel proteasome inhibitor ixazomib sensitizes neuroblastoma cells to doxorubicin treatment.
P2860
Q21195237-4716EB58-1C7A-48E5-987B-F1D7CE7CF351Q26849940-6DB1FC6D-FE15-41A7-A486-CD3D64B9F8A5Q28397872-8BA4157B-E946-4787-8A42-3643660ED359Q28540744-22FE394D-DAFE-4CF3-8556-1DA108101E2EQ30275870-B2278D3E-8950-4ADB-91AF-37D67B97B1CEQ33622430-F479402B-2568-42B8-9029-B3DF935767CFQ33884616-576CBBC5-CEA6-4E30-B13C-A341BFE86EE5Q33895135-FB388A65-4BE8-4971-B0CB-2A1CEB7A6AB1Q34053504-267AD81A-1741-45A2-9FDC-48571F80FBB9Q34195083-AD009914-AD4E-4F2A-96B4-E934F2323981Q34473291-9B0588D9-B53F-4873-A6E9-7FD9D583B01CQ34542978-B415AC1C-6AF0-4D0A-8892-9BAD9544D060Q34788381-1D4C690F-5799-484C-89FB-127109BE274BQ35216231-A19CB88D-2251-4028-8F52-B4F132243946Q35663874-E8321A4C-5B9F-4F8E-A5FC-6A38021A1FCFQ35828469-4FE8E4A3-8172-4894-A71F-0148176953EEQ35832539-C1491959-72D4-4BD5-9906-D0A2D93175D6Q35836881-416C9DD0-FD3E-4740-A0CB-3D791E87FE20Q35846736-5E46A93B-75C0-43BD-9822-271870516F9FQ36080090-0F2B4192-185D-4878-8C7C-1446D59B7D51Q36157320-07B527A7-6DC2-4A57-B527-09D6BF22BF98Q36189599-AC18349C-B585-40B8-AC1F-DF5DB086EB17Q36309873-696D46BA-1391-4279-B5B9-56765F7F5FF6Q36465296-22824313-3C68-4E92-B49A-1F72FE864A0CQ36610398-6565455E-239C-4D7A-A9FF-61B138DD9452Q36822739-FDD93736-B2B0-48A9-B5E9-00E1A2F9F2E2Q36837031-0B12F0A5-06B9-4027-B28C-1804D007FB32Q36869057-1255A4EE-4A2E-40C1-8966-B8F6F3DF5166Q36900376-DC004DEB-C9FC-4558-A14B-E15EA465BD4BQ36916903-1F65C809-5838-47C3-AF25-1E37E473F1A7Q36952604-C65A0370-DC23-41ED-A9ED-A2D2711AA667Q37137649-6F6D6C28-AB77-4917-A770-2094E1F5266BQ37142312-92D7CC58-244D-4712-940A-B5AFFA5AFD03Q37148849-6DF99318-9E86-436F-ADE2-8F26290D095BQ37154960-2A4AB06E-651F-44B4-ADCE-E3424F0AA8CBQ37161937-401AEE22-9AAF-4D16-A5A2-72232B45687BQ37175850-FB62F497-F3D4-4326-B6D4-15F0958D6786Q37184067-30995FE6-E283-4BB1-B93C-C310050DB6BDQ37189804-B72D78F2-51DA-4C35-A459-2FE1AE9E75D0Q37298880-E5514723-A79E-4E1B-AEE2-99E507416486
P2860
Proteasome inhibitors as potential novel anticancer agents.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Proteasome inhibitors as potential novel anticancer agents.
@ast
Proteasome inhibitors as potential novel anticancer agents.
@en
Proteasome inhibitors as potential novel anticancer agents.
@nl
type
label
Proteasome inhibitors as potential novel anticancer agents.
@ast
Proteasome inhibitors as potential novel anticancer agents.
@en
Proteasome inhibitors as potential novel anticancer agents.
@nl
prefLabel
Proteasome inhibitors as potential novel anticancer agents.
@ast
Proteasome inhibitors as potential novel anticancer agents.
@en
Proteasome inhibitors as potential novel anticancer agents.
@nl
P356
P1476
Proteasome inhibitors as potential novel anticancer agents.
@en
P2093
P304
P356
10.1054/DRUP.1999.0095
P577
1999-08-01T00:00:00Z